ÂÜÀòÂÒÂ×

Hanns Mohler serves as the Head of Pharmacology at Panavance Therapeutics Inc. since March 2022 and is a Professor em. of Pharmacology at the Institute of Pharmacology, ETH Zurich, and University of Zurich since April 1988. Mohler has held various prestigious roles, including Professor of Pharmacology and Director, while also being a member of both the Swiss Academy of Medical Sciences and the European Academy of Sciences (Academia Europaea). Previous positions include Senior Consultant roles at Geistlich Pharma AG, GSK Verona, and Roche, as well as a consulting position with HBM Bioventures. Before these roles, Mohler was a Professor of Biochemistry at the University of Freiburg and Vice Director (Science) at Roche's Research Department. Education includes a Dr. rer. nat. in Biochemistry from multiple esteemed institutions, including the Universities of Tübingen and Freiburg.